Literature DB >> 34176828

Digestive Decolonization of Colorectal Carriage of Vancomycin-resistant Enterococcus faecium in a Japanese Adult.

Shunsuke Uno1,2, Yaoko Takano2, Osamu Iketani2, Tomohiro Abiko3, Tomoru Miwa3, Kosaku Nanki4, Tomohiro Kurihara2,5, Yuko Tamura2, Miyuki Ara2, Yoshifumi Uwamino2,6, Masayoshi Shinjoh2,7, Takehiko Mori2,8, Naoki Hasegawa1,2.   

Abstract

Patients with vancomycin-resistant Enterococcus (VRE) colonization should be managed in an isolation room with contact precautions. We herein report a patient whose colorectal carriage of VRE was successfully decolonized using concomitant bowel irrigation with polyethylene glycol, probiotics, and oral antimicrobials, linezolid and orally-administered daptomycin, for release from isolation and contact precautions. We therefore would like to suggest a potential strategy for managing patients with VRE colonization.

Entities:  

Keywords:  decolonization; isolation precautions; vancomycin-resistant Enterococcus

Mesh:

Substances:

Year:  2021        PMID: 34176828      PMCID: PMC8851193          DOI: 10.2169/internalmedicine.6088-20

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


Introduction

The prevalence of vancomycin-resistant Enterococcus (VRE) is increasing worldwide (1,2), and VRE infections pose a severe threat to public health. VRE bacteremia is associated with a higher case fatality and longer hospital stay than vancomycin-susceptible Enterococcus species (3). Patients with VRE colonization are managed by implementing isolation precautions in medical facilities (4). However, rehabilitation hospitals and long-term care facilities with expertise in hygiene practices and sufficient paramedical staff that adhere to these isolation protocols for managing multidrug-resistant organisms (MDROs), including VRE, are limited in Japan. Managing patients who need to be hospitalized following the detection of an MDRO in a culture specimen is a serious infection control concern, even though spontaneous decolonization is noted in 48.2% of MDRO colonization cases (5). VRE decolonization is a potential choice for preventing hospital transmission of VRE. However, efficient decolonization strategies have not yet been established, although the potential efficacy of fecal microbiota transplantation (FMT) (6,7) and antimicrobial decolonization regimes (8) have previously been reported. We herein report a patient treated using concomitant bowel irrigation with polyethylene glycol (PEG), probiotics, and the oral administration of the antimicrobials, linezolid and daptomycin, for VRE decolonization.

Case Report

A 60-year-old man with no relevant medical history was admitted to Keio University Hospital, a tertiary-care hospital with 1,044 beds, for acute aortic dissection involving right brain infarction. Despite emergency ascending aortic arch replacement and extracranial decompression on the day of admission, he suffered from left hemiparesis and altered consciousness, after which he was bed-ridden and required nursing care. Two months later, surgical site infection was observed following skull reconstruction (using thigh fascia lata), for which the patient was prescribed broad-spectrum antimicrobial therapy for eight weeks. The patient was transferred to the rehabilitation hospital a further two months later. However, he was immediately re-admitted to our hospital because of vancomycin-resistant Enterococcus faecium colonization, as confirmed by a rectal swab culture. Polymerase chain reaction was performed using Xpert vanA/vanB (Cepheid, Sunnyvale, USA) for the recovered VRE colony, and the presence of the vanA gene was confirmed. The minimum inhibitory concentration of daptomycin and linezolid for this strain was 2 mg/dL and <2 mg/dL, respectively. We implemented contact isolation precautions and checked rectal swab cultures for the clearance of VRE colonization. The patient needed further rehabilitation to improve his activities of daily living. However, no rehabilitation hospital or long-term care facilities would admit him owing to their lack of expertise in the necessary hygiene practices and insufficient paramedical staff able to adhere to the isolation precautions. VRE was detected in rectal swab cultures for one year following re-admission to our hospital. Owing to the prolonged hospital stay and unsuccessful spontaneous clearance of VRE, VRE decolonization was considered. A decolonization protocol was prepared (Figure) by referring to a previous report (8). The protocol was approved by the clinical ethics consultation of Keio University Hospital (2018-13). The patient was isolated in room A before decolonization. A naso-duodenal (ND) tube was inserted three days before decolonization, and a cuff rectum drainage tube was inserted a day before decolonization was performed by bowel irrigation with PEG. Two liters of PEG was infused via the ND tube over six hours to wash out the bowel contents, and we noted that the defecated bowel content was a clear fluid on the starting day (Day 0). The patient was bathed with soap and shampoo, and his clothes and linens were replaced every day. A five-day dose of antimicrobials against VRE was prescribed that included linezolid 600 mg twice a day and orally administered daptomycin 8 mg/kg/day. Enteral feeding was stopped on Day 0 and restarted on Day 1.
Figure.

Protocol for vancomycin-resistant Enterococcus faecium decolonization. PEG: polyethylene glycol

Protocol for vancomycin-resistant Enterococcus faecium decolonization. PEG: polyethylene glycol The patient was transferred to isolation room B after bathing on Day 1. Removal of the cuff rectum drainage tube was planned on the evening of Day 0; however, the removal was deferred to Day 7 due to prolonged diarrhea. Probiotics administration, involving a mixture of the products derived from E. faecalis and Bacillus subtilis, Biofermin powder (Biofermin Pharm, Kobe, Japan) 9 g/day, divided into 3 doses; and Clostridium butyricum, Miya-BM fine granules (Miyarisan Pharm, Tokyo, Japan) 3 g/day, divided into 3 doses, was initiated after the completion of antimicrobial therapy. Probiotics were continued until the patient was discharged. Rectal swab cultures were obtained at planned intervals starting at one week, one month, three months, and six months after initiating the decolonization protocol on VRE Selective Agar (Becton Dickinson, Franklin Lakes, USA). VRE was not detected in any of the rectal swab cultures despite two-week antimicrobial treatment with cefepime following piperacillin/tazobactam for a urinary tract infection four months after decolonization. No severe adverse events were observed during the decolonization process; however, the removal of the cuff rectum drainage tube was deferred until Day 7 because of prolonged diarrhea. The introduction of this protocol allowed a cost-savings of 1,690,732 yen (approximately 15,650 USD) per year in gowns and gloves, which was calculated by multiplying the actual price delivered to the hospital by the estimated number of gloves and gowns used in 1 year, while 281,000 yen (approximately 2,600 USD) was spent on instruments and drugs. The number of gloves and gowns used per year was estimated by multiplying the average number of gloves and gowns used per week by 52.

Discussion

We reported our management of a patient who underwent decolonization of VRE using an antimicrobial method after an extended period of compliance with contact isolation precautions and unsuccessful spontaneous VRE clearance. VRE was not detected in the rectal swab cultures for six months after decolonization, and no severe adverse events were observed, indicating successful decolonization. Thus, the isolation measures were relaxed. We also saved approximately 1.41 million yen (approximately 13,053 USD) per year by reducing the use of personal protective equipment for contact precautions after deducting the price of the instruments and drugs used for decolonization. Managing patients with VRE colonization is a serious challenge in infection control. Some studies have suggested that patient isolation may not be the best measure of preventing infection (9,10). However, these reports are based on the endemicity of VRE on different levels. Data from the Japan Nosocomial Infections Surveillance suggest that the annual recovery rate of VRE from 2013 to 2018 was <1% (11,12). Even a single detection at a facility, irrespective of whether it causes infectious disease, should be considered an outbreak. Based on these data, the discontinuation of isolation precautions in Japan should be duly considered. Owing to the limited number of facilities with expertise in hygiene and sufficient paramedical staff that strictly follow isolation precautions in Japan, decolonization is a meaningful strategy for achieving infection control. Decolonization of VRE using antimicrobials is challenging. Selective bowel decolonization is reportedly effective in only 35% of liver or kidney transplant patients (13). One study mentioned an improved method that combined antimicrobials against Enterococcus spp. with mechanical preparations of PEG, which is commonly used before colonoscopy (8). To reduce the total bacterial burden and increase the probability of successful decolonization, our protocol was devised by referring to the methods used in a previous study (8). Another study reported not only re-colonization of VRE after hematopoietic stem cell transplantation but also showed that exposure to antimicrobials may increase the likelihood of re-colonization (14). Our patient's rectal swab cultures remained negative despite the administration of piperacillin/tazobactam and cefepime for urinary tract infection four months after decolonization. This implies that the regimen followed in this case markedly decreased the intestinal bacterial load of VRE. As mentioned in several studies, clearance of VRE colonization is controversial, and it may take up to three or four consecutive negative cultures one or more weeks apart to identify successful decolonization (5,7,13,14). Thus, to confirm successful decolonization, we obtained rectal swab cultures until six months after decolonization, as previously reported (6), using a selective medium with increased sensitivity of detection. The criteria of which patients should be decolonized and the strategy of decolonization have not yet been established. Although there are no reports that clearly indicate how long an observation period is required to achieve spontaneous clearance, a previous systematic review showed that spontaneous clearance of VRE colonization was seen in half of cases at 26 weeks from the time of documented colonization (15). Another retrospective study showed that 56.8% of patients with VRE colonization demonstrated clearance within a median follow-up duration of 382 days (16). Therefore, if spontaneous clearance is not obtained within 6 to 12 months, it might be reasonable to consider decolonization, depending on the need. A previous report suggested two strategies - FMT and an antimicrobial method - for decolonizing VRE (6-8); the advantages of the antimicrobial decolonization method may be its simplicity and acceptance by the patient and family. We presented both options to this patient, and the family chose the antimicrobial method. The disadvantage of antimicrobial decolonization is the possibility of side effects. Daptomycin is not likely to be a problem because of its low oral bioavailability (17); however, linezolid may cause high rates of thrombocytopenia in Japanese patients after use for more than a week (18). In addition, further resistant bacteria might emerge due to the use of antimicrobials. However, in the present case, the risk of either of these occurring was not considered high, as both were administered for only five days. In conclusion, this report suggests a potential strategy for decolonizing colorectal VRE to manage patients with VRE colonization in resource-limited medical facilities. The institutional review board of Keio University School of Medicine approved this study (20170385), and informed consent was obtained from the next of kin of the patient. The authors state that they have no Conflict of Interest (COI).
  17 in total

Review 1.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 2.  Vancomycin-resistant enterococci (VRE): a reason to isolate?

Authors:  Maria J G T Vehreschild; Miriam Haverkamp; Lena M Biehl; Sebastian Lemmen; Gerd Fätkenheuer
Journal:  Infection       Date:  2018-09-03       Impact factor: 3.553

3.  Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients.

Authors:  R Patel; S L Allen; J M Manahan; A J Wright; R A Krom; R H Wiesner; D H Persing; F R Cockerill; R L Thompson
Journal:  Liver Transpl       Date:  2001-01       Impact factor: 5.799

4.  Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy.

Authors:  Yoshiko Takahashi; Yoshio Takesue; Kazuhiko Nakajima; Kaoru Ichiki; Toshie Tsuchida; Sumiyo Tatsumi; Mika Ishihara; Hiroki Ikeuchi; Motoi Uchino
Journal:  J Infect Chemother       Date:  2010-12-03       Impact factor: 2.211

5.  Fecal Microbiota Transplantation in Patients With Blood Disorders Inhibits Gut Colonization With Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study.

Authors:  Jaroslaw Bilinski; Pawel Grzesiowski; Nikolaj Sorensen; Krzysztof Madry; Jacek Muszynski; Katarzyna Robak; Marta Wroblewska; Tomasz Dzieciatkowski; Grazyna Dulny; Jadwiga Dwilewicz-Trojaczek; Wieslaw Wiktor-Jedrzejczak; Grzegorz W Basak
Journal:  Clin Infect Dis       Date:  2017-08-01       Impact factor: 9.079

6.  A retrospective cohort study of antibiotic exposure and vancomycin-resistant Enterococcus recolonization.

Authors:  Heather Y Hughes; Robin T Odom; Angela V Michelin; Evan S Snitkin; Ninet Sinaii; Aaron M Milstone; David K Henderson; Tara N Palmore
Journal:  Infect Control Hosp Epidemiol       Date:  2019-02-07       Impact factor: 3.254

7.  Noninfectious Hospital Adverse Events Decline After Elimination of Contact Precautions for MRSA and VRE.

Authors:  Elise M Martin; Brandy Bryant; Tristan R Grogan; Zachary A Rubin; Dana L Russell; David Elashoff; Daniel Z Uslan
Journal:  Infect Control Hosp Epidemiol       Date:  2018-05-10       Impact factor: 3.254

8.  Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study.

Authors:  A Dinh; H Fessi; C Duran; R Batista; H Michelon; F Bouchand; R Lepeule; D Vittecoq; L Escaut; I Sobhani; C Lawrence; F Chast; P Ronco; B Davido
Journal:  J Hosp Infect       Date:  2018-03-02       Impact factor: 3.926

Review 9.  Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature.

Authors:  Vincent C C Cheng; Jonathan H K Chen; Josepha W M Tai; Sally C Y Wong; Rosana W S Poon; Ivan F N Hung; Kelvin K W To; Jasper F W Chan; Pak-Leung Ho; Chung-Mau Lo; Kwok-Yung Yuen
Journal:  BMC Infect Dis       Date:  2014-09-23       Impact factor: 3.090

10.  Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratories.

Authors:  Atsuko Tsutsui; Satowa Suzuki
Journal:  BMC Health Serv Res       Date:  2018-10-20       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.